Ana Coloma

856 total citations
28 papers, 519 citations indexed

About

Ana Coloma is a scholar working on Transplantation, Nephrology and Infectious Diseases. According to data from OpenAlex, Ana Coloma has authored 28 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Transplantation, 7 papers in Nephrology and 6 papers in Infectious Diseases. Recurrent topics in Ana Coloma's work include Renal Transplantation Outcomes and Treatments (12 papers), Pharmacological Effects and Toxicity Studies (6 papers) and HIV/AIDS drug development and treatment (4 papers). Ana Coloma is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Pharmacological Effects and Toxicity Studies (6 papers) and HIV/AIDS drug development and treatment (4 papers). Ana Coloma collaborates with scholars based in Spain, United States and Uruguay. Ana Coloma's co-authors include Benito Almirante, Jesús Rodríguez‐Baño, Gemma Navarro, Álvaro Pascual, Carmen Peña, José Ramón Hernández, Javier Colomina, Antonio Oliver, Fabio Grill and Paloma Gijón and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Kidney International.

In The Last Decade

Ana Coloma

22 papers receiving 507 citations

Peers

Ana Coloma
Myrto Eleni Flokas United States
Marie Abdallah United States
Rossella Buttazzi Italy
Meghan Gavaghan United States
Vildan Avkan-Oğuz Türkiye
Cruz Soriano Spain
Jaime Lora-Tamayo Spain
Hande Aydemir Türkiye
Panagiota Lourida Greece
Isabel Oriol Spain
Myrto Eleni Flokas United States
Ana Coloma
Citations per year, relative to Ana Coloma Ana Coloma (= 1×) peers Myrto Eleni Flokas

Countries citing papers authored by Ana Coloma

Since Specialization
Citations

This map shows the geographic impact of Ana Coloma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Coloma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Coloma more than expected).

Fields of papers citing papers by Ana Coloma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Coloma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Coloma. The network helps show where Ana Coloma may publish in the future.

Co-authorship network of co-authors of Ana Coloma

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Coloma. A scholar is included among the top collaborators of Ana Coloma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Coloma. Ana Coloma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pareja, L., Josepa Ribes, Jordi Comas, et al.. (2025). Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21. Clinical Kidney Journal. 18(4). sfaf077–sfaf077. 3 indexed citations
2.
Madrigal‐Burgaleta, Ricardo, et al.. (2025). Oxaliplatin-induced type II hypersensitivity in colorectal cancer: a cohort study on clinical presentation, diagnosis, and management. Frontiers in Pharmacology. 16. 1605690–1605690.
3.
Coloma, Ana, Núria Lloberas, Alexandre Favà, et al.. (2024). Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis. Transplantation Reviews. 38(3). 100856–100856. 7 indexed citations
4.
Favà, Alexandre, Laura Calatayud, Edoardo Melilli, et al.. (2024). Hybrid immunity protection against SARS-CoV-2 and severe COVID-19 in kidney transplantation: A retrospective, comparative cohort study. American Journal of Transplantation. 24(12). 2282–2291. 1 indexed citations
5.
Vidal‐Alabró, Anna, Raül Rigo‐Bonnin, Josep M. Grinyó, et al.. (2024). Guiding the starting dose of the once-daily formulation of tacrolimus in “de novo” adult renal transplant patients: a population approach. Frontiers in Pharmacology. 15. 1456565–1456565. 1 indexed citations
6.
Vidal‐Alabró, Anna, Helena Colom, Pere Fontova, et al.. (2024). Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio. Nefrología (English Edition). 44(2). 204–216. 4 indexed citations
7.
8.
9.
Fontova, Pere, Anna Vidal‐Alabró, Raül Rigo‐Bonnin, et al.. (2023). The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations. Pharmaceutics. 15(5). 1481–1481. 6 indexed citations
10.
Lloberas, Núria, Josep M. Grinyó, Helena Colom, et al.. (2023). A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction. Kidney International. 104(4). 840–850. 22 indexed citations
11.
Buxeda, Anna, Fernando Caravaca‐Fontán, Ana Coloma, et al.. (2023). High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation. Clinical Kidney Journal. 16(10). 1644–1655. 3 indexed citations
12.
Rama, Inés, Jordi Comas, Núria Montero, et al.. (2022). Effect of kidney replacement therapy modality after first kidney graft failure on second kidney transplantation outcomes. Clinical Kidney Journal. 15(11). 2046–2055. 7 indexed citations
13.
Melilli, Edoardo, Ignacio Revuelta, María Meneghini, et al.. (2021). Adoption of a novel smart mobile‐health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot study. Clinical Transplantation. 35(5). e14278–e14278. 13 indexed citations
14.
Montero, Núria, Emma Arcos, Jordi Comas, et al.. (2019). Effects of body weight variation in obese kidney recipients: a retrospective cohort study. Clinical Kidney Journal. 13(6). 1068–1076. 5 indexed citations
15.
Coloma, Ana, et al.. (2017). Parálisis muscular hipopotasémica secundaria al consumo excesivo de bebidas con cola. 9(2). 103–106.
16.
Angioi, Andrea, Nicola Lepori, Ana Coloma, et al.. (2017). Treatment of primary membranous nephropathy: where are we now?. Journal of Nephrology. 31(4). 489–502. 14 indexed citations
17.
Cervera‐Acedo, Cristina, et al.. (2017). Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene. BMC Nephrology. 18(1). 325–325. 9 indexed citations
18.
Revuelta, Ignacio, et al.. (2016). Relationship Between Vitamin D Blood Levels and Cancer Development in Renal Transplant Patients: A Case-Control Study. Transplantation Proceedings. 48(9). 2959–2961. 4 indexed citations
19.
Coloma, Ana, et al.. (2016). Primary hyperparathyroidism regression associated to cinacalcet therapy proved by 99mTc-MIBI scintigraphy. Revista Española de Medicina Nuclear e Imagen Molecular. 36(2). 120–121. 1 indexed citations
20.
Rodríguez‐Baño, Jesús, Paloma Gijón, José Ramón Hernández, et al.. (2009). Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis. Clinical Infectious Diseases. 50(1). 40–48. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myrto Eleni Flokas Breakdown of academic impact, for papers by Marie Abdallah Breakdown of academic impact, for papers by Rossella Buttazzi Breakdown of academic impact, for papers by Meghan Gavaghan Breakdown of academic impact, for papers by Vildan Avkan-Oğuz Breakdown of academic impact, for papers by Cruz Soriano Breakdown of academic impact, for papers by Jaime Lora-Tamayo Breakdown of academic impact, for papers by Hande Aydemir Breakdown of academic impact, for papers by Panagiota Lourida Breakdown of academic impact, for papers by Isabel Oriol
Rankless by CCL
2026